n = 40 | |
Age, median (range) | 30.5 years (19–85 years) |
Gender | |
Male | 21 |
Female | 19 |
B symptoms | |
Positive | 24 |
Negative | 16 |
LDH | |
Normal | 4 |
Elevated | 36 |
ESR | |
Normal | 0 |
Elevated | 40 |
Ann Arbor stage | |
I | 8 |
II | 18 |
III | 6 |
IV | 8 |
Histology | |
Nodular sclerosis | 24 |
Mixed cellularity | 16 |
Target lesions | |
LNs | 75 |
Other lesions | 17 |
Splenic lesions | 10 |
Bone lesions | 8 |
RECIL response to CTH | |
Complete response | 26 |
Partial response* | 8 |
Minor response** | 4 |
Stable disease | 0 |
Progressive disease | 2 |